Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Oct, 2019 | Pages:
90 | Publisher: Grand View Research
Industry: Medical Devices | Report Format: Electronic (PDF)
The global drug delivery across blood brain barrier market size is expected to reach USD 4.6 billion by 2026, according to a new report by Grand View Research, Inc. registering a CAGR of 30.2% over the forecast period. Growing research, innovation, and treatment development activities to overcome the challenges faced due to the natural blood brain barrier is majorly driving the market growth. Growing prevalence of neurological diseases, such as Parkinson's and Alzheimer's disease is fueling the demand for novel drug delivery technology that allows medication to cross the blood brain barrier. Limited treatment options regarding blood-brain barrier has been a big hurdle till recently. However, the growing demand for treatment and the rise in innovations that allow for safe and reliable transmission of medication across the BBB is predicted to drive the market's growth over the forecast period. Among the recently developed technologies, increasing permeability of the BBB via ultrasound is the most promising one that has shown safe and effective application in treating various patients with brain cancer and other neurogenetical disorders. Other novel technologies such as in-vitro BBB modeling/engineering is being used for producing a faster, reliable, and cost-effective drug delivery mechanism for overcoming the complexities of BBB. Increasing use of engineered antibiotics are being tested as a technique for delivering cures for severe brain disorders, such as Alzheimer's and Hunter's disease. Such antibiotics are expected to greatly increase the convenience of treatment, in addition to the increased effectivity. Further key findings from the report suggest: • Based on the drug delivery technology, increasing permeability of BBB segment registered significant share of the drug delivery across blood brain barrier market owing to successful ultrasound device technology that have been deemed effective in providing therapies for treating brain disorders • Trojan horse approach segment is expected to lead the market soon, since engineered antibodies have been observed to provide reliable and safe medical treatment for various cancer, immunity, and genetic disorder's treatment • Based on application, Parkinson's disorder segment held maximum share in the market in 2018 owing to increased incidences of the targeted disorder among the growing geriatric population worldwide. Many major economies in EU and Asia are expected to significantly observe a growth in geriatric population by 2050. • Asia Pacific is anticipated to lead this market over the forecast period owing to rising geriatric population that may be prone to brain disorders and opportunity for the industry players due to medical tourism in the region. However, by revenue, North America shall continue to be the largest market due to the high cost of healthcare treatment. • Some of the players profiled in drug delivery across blood brain barrier market include Ossianix, Inc., Insightec, Angiochem Inc., Armagen Technologies, Inc., BrainsGate, BiOasis Technologies, Inc., CarThera, F. Hoffman La-Roche, and Iproteos S.L.
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Drug delivery technology
1.1.2. Application
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR's internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1: Understanding the market dynamics
1.9.2. Objective 2: Understanding the market estimates and forecasts
1.9.3. Objective 3: Understanding the attributes such as strategy framework, competitor categorization
1.9.4. Objective 4: Understanding the key product and application scopes to conclude on the market size
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Drug Delivery across Blood Brain Barrier Market Variables, Trends & Scope
3.1. Market Lineage outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Product Pipeline Analysis, by Stage
3.4. Market Dynamics
3.4.1. Market Driver Analysis
3.4.1.1. Increasing incidences of Neurodegenerative disorders
3.4.1.2. Increasing diagnosis of brain tumor
3.4.2. Market Restraint Analysis
3.4.2.1. Complications in brain medication delivery and biopsy poses
3.4.3. Industry Challenges
3.5. Drug Delivery across Blood Brain Barrier: Market Analysis Tools
3.5.1. Industry Analysis - Porter's
3.5.1.1. Supplier Power
3.5.1.2. Buyer Power
3.5.1.3. Substitution Threat
3.5.1.4. Threat from new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political Landscape
3.5.2.2. Environmental Landscape
3.5.2.3. Social Landscape
3.5.2.4. Technology Landscape
3.5.2.5. Legal Landscape
3.5.3. Major Deals & Strategic Alliances Analysis
Chapter 4. Drug Delivery across Blood Brain Barrier Market: Segment Analysis, by Drug Delivery Technology, 2016 - 2026 (USD Million)
4.1. Definitions & Scope
4.2. Drug delivery technology market share analysis, 2018 & 2026
4.3. Segment Dashboard
4.4. Global Drug Delivery across Blood Brain Barrier Market, by Drug delivery technology, 2016 to 2026
4.5. Market Size & Forecasts and Trend Analyses, 2016 to 2026 for the following
4.5.1. Trojan Horse Approach Drug Delivery across Blood Brain Barrier
4.5.2. Bispecific Antibody RMT Approach Drug Delivery across Blood Brain Barrier
4.5.3. Increasing the Permeability of BBB Drug Delivery across Blood Brain Barrier
4.5.4. Passive Diffusion Drug Delivery across Blood Brain Barrier
4.5.5. Other Non-Invasive BBB Technologies Drug Delivery across Blood Brain Barrier
Chapter 5. Drug Delivery across Blood Brain Barrier Market: Segment Analysis, By Application, 2016 - 2026 (USD Million)
5.1. Definitions & Scope
5.2. Application market share analysis, 2018 & 2026
5.3. Segment Dashboard
5.4. Global Drug Delivery across Blood Brain Barrier Market, By Application, 2016 to 2026
5.5. Market Size & Forecasts and Trend Analyses, 2016 to 2026 for the following
5.5.1. Alzheimer's Disease
5.5.2. Epilepsy
5.5.3. Parkinson's Disease
5.5.4. Multiple Sclerosis
5.5.5. Hunter's Syndrome
5.5.6. Brain Cancer
5.5.7. Others
Chapter 6. Drug Delivery across Blood Brain Barrier Market: Regional Market Analysis, by Drug delivery technology, 2016 - 2026 (USD Million)
6.1. Definitions & Scope
6.2. Regional Market Share Analysis, 2018 & 2026
6.3. Regional Market Dashboard
6.4. Regional Market Snapshot
6.5. Regional Market Share, 2018
6.6. Market Size, & Forecasts, and Trend Analysis, 2016 to 2026:
6.7. North America
6.7.1. Market estimates and forecast, by country, 2016 - 2026 (USD Million)
6.7.2. Market estimates and forecast, by drug delivery technology, 2016 - 2026 (USD Million)
6.7.3. Market estimates and forecast, by application, 2016 - 2026 (USD Million)
6.7.4. U.S.
6.7.4.1. Market estimates and forecast, by drug delivery technology, 2016 - 2026 (USD Million)
6.7.4.2. Market estimates and forecast, by application, 2016 - 2026 (USD Million)
6.7.5. Canada
6.7.5.1. Market estimates and forecast, by drug delivery technology, 2016 - 2026 (USD Million)
6.7.5.2. Market estimates and forecast, by application, 2016 - 2026 (USD Million)
6.8. Europe
6.8.1. Market estimates and forecast, by country, 2016 - 2026 (USD Million)
6.8.2. Market estimates and forecast, by drug delivery technology, 2016 - 2026 (USD Million)
6.8.3. Market estimates and forecast, by application, 2016 - 2026 (USD Million)
6.8.4. U.K.
6.8.4.1. Market estimates and forecast, by drug delivery technology, 2016 - 2026 (USD Million)
6.8.4.2. Market estimates and forecast, by application, 2016 - 2026 (USD Million)
6.8.5. Germany
6.8.5.1. Market estimates and forecast, by drug delivery technology, 2016 - 2026 (USD Million)
6.8.5.2. Market estimates and forecast, by application, 2016 - 2026 (USD Million)
6.8.6. France
6.8.6.1. Market estimates and forecast, by drug delivery technology, 2016 - 2026 (USD Million)
6.8.6.2. Market estimates and forecast, by application, 2016 - 2026 (USD Million)
6.8.7. Italy
6.8.7.1. Market estimates and forecast, by drug delivery technology, 2016 - 2026 (USD Million)
6.8.7.2. Market estimates and forecast, by application, 2016 - 2026 (USD Million)
6.8.8. Spain
6.8.8.1. Market estimates and forecast, by drug delivery technology, 2016 - 2026 (USD Million)
6.8.8.2. Market estimates and forecast, by application, 2016 - 2026 (USD Million)
6.9. Asia Pacific
6.9.1. Market estimates and forecast, by country, 2016 - 2026 (USD Million)
6.9.2. Market estimates and forecast, by drug delivery technology, 2016 - 2026 (USD Million)
6.9.3. Market estimates and forecast, by application, 2016 - 2026 (USD Million)
6.9.4. Japan
6.9.4.1. Market estimates and forecast, by drug delivery technology, 2016 - 2026 (USD Million)
6.9.4.2. Market estimates and forecast, by application, 2016 - 2026 (USD Million)
6.9.5. China
6.9.5.1. Market estimates and forecast, by drug delivery technology, 2016 - 2026 (USD Million)
6.9.5.2. Market estimates and forecast, by application, 2016 - 2026 (USD Million)
6.9.6. India
6.9.6.1. Market estimates and forecast, by drug delivery technology, 2016 - 2026 (USD Million)
6.9.6.2. Market estimates and forecast, by application, 2016 - 2026 (USD Million)
6.9.7. Thailand
6.9.7.1. Market estimates and forecast, by drug delivery technology, 2016 - 2026 (USD Million)
6.9.7.2. Market estimates and forecast, by application, 2016 - 2026 (USD Million)
6.9.8. South Korea
6.9.8.1. Market estimates and forecast, by drug delivery technology, 2016 - 2026 (USD Million)
6.9.8.2. Market estimates and forecast, by application, 2016 - 2026 (USD Million)
6.10. Latin America
6.10.1. Market estimates and forecast, by country, 2016 - 2026 (USD Million)
6.10.2. Market estimates and forecast, by drug delivery technology, 2016 - 2026 (USD Million)
6.10.3. Market estimates and forecast, by application, 2016 - 2026 (USD Million)
6.10.4. Brazil
6.10.4.1. Market estimates and forecast, by drug delivery technology, 2016 - 2026 (USD Million)
6.10.4.2. Market estimates and forecast, by application, 2016 - 2026 (USD Million)
6.10.5. Mexico
6.10.5.1. Market estimates and forecast, by drug delivery technology, 2016 - 2026 (USD Million)
6.10.5.2. Market estimates and forecast, by application, 2016 - 2026 (USD Million)
6.10.6. Argentina
6.10.6.1. Market estimates and forecast, by drug delivery technology, 2016 - 2026 (USD Million)
6.10.6.2. Market estimates and forecast, by application, 2016 - 2026 (USD Million)
6.10.7. Colombia
6.10.7.1. Market estimates and forecast, by drug delivery technology, 2016 - 2026 (USD Million)
6.10.7.2. Market estimates and forecast, by application, 2016 - 2026 (USD Million)
6.11. Middle East and Africa
6.11.1. Market estimates and forecast, by country, 2016 - 2026 (USD Million)
6.11.2. Market estimates and forecast, by drug delivery technology, 2016 - 2026 (USD Million)
6.11.3. Market estimates and forecast, by application, 2016 - 2026 (USD Million)
6.11.4. South Africa
6.11.4.1. Market estimates and forecast, by drug delivery technology, 2016 - 2026 (USD Million)
6.11.4.2. Market estimates and forecast, by application, 2016 - 2026 (USD Million)
6.11.5. Saudi Arabia
6.11.5.1. Market estimates and forecast, by drug delivery technology, 2016 - 2026 (USD Million)
6.11.5.2. Market estimates and forecast, by application, 2016 - 2026 (USD Million)
6.11.6. UAE
6.11.6.1. Market estimates and forecast, by drug delivery technology, 2016 - 2026 (USD Million)
6.11.6.2. Market estimates and forecast, by application, 2016 - 2026 (USD Million)
Chapter 7. Drug Delivery across Blood Brain Barrier Market - Competitive Analysis
7.1. Key companies profiled
7.1.1. Ossianix, Inc.
7.1.1.1. Company Overview
7.1.1.2. Financial Performance
7.1.1.3. Product Benchmarking
7.1.1.4. Strategic Initiatives
7.1.2. Insightec
7.1.2.1. Company Overview
7.1.2.2. Financial Performance
7.1.2.3. Product Benchmarking
7.1.2.4. Strategic Initiatives
7.1.3. Angiochem Inc.
7.1.3.1. Company Overview
7.1.3.2. Financial Performance
7.1.3.3. Product Benchmarking
7.1.3.4. Strategic Initiatives
7.1.4. Armagen Technologies, Inc.
7.1.4.1. Company Overview
7.1.4.2. Financial Performance
7.1.4.3. Product Benchmarking
7.1.4.4. Strategic Initiatives
7.1.5. BrainsGate
7.1.5.1. Company Overview
7.1.5.2. Financial Performance
7.1.5.3. Product Benchmarking
7.1.5.4. Strategic Initiatives
7.1.6. BiOasis Technologies, Inc.
7.1.6.1. Company Overview
7.1.6.2. Financial Performance
7.1.6.3. Product Benchmarking
7.1.6.4. Strategic Initiatives
7.1.7. CarThera
7.1.7.1. Company Overview
7.1.7.2. Financial Performance
7.1.7.3. Product Benchmarking
7.1.7.4. Strategic Initiatives
7.1.8. F. Hoffman La-Roche
7.1.8.1. Company Overview
7.1.8.2. Financial Performance
7.1.8.3. Product Benchmarking
7.1.8.4. Strategic Initiatives
7.1.9. Iproteos S.L
7.1.9.1. Company Overview
7.1.9.2. Financial Performance
7.1.9.3. Product Benchmarking
7.1.9.4. Strategic Initiatives
List of Tables Table 1 List of Secondary Sources Table 2 List of Abbreviations Table 3 Global Drug Delivery across Blood Brain Barrier Market, By Region 2016 - 2026 (USD Million) Table 4 Global Drug Delivery across Blood Brain Barrier Market, By Application, 2016 - 2026 (USD Million) Table 5 Global Drug Delivery across Blood Brain Barrier Market, By Drug Delivery Technology, 2016 - 2026 (USD Million) Table 6 North America Drug Delivery across Blood Brain Barrier Market, By Country, 2016 - 2026 (USD Million) Table 7 North America Drug Delivery across Blood Brain Barrier Market, By Application, 2016 - 2026 (USD Million) Table 8 North America Drug Delivery across Blood Brain Barrier Market, By Drug Delivery Technology, 2016 - 2026 (USD Million) Table 9 U.S. Drug Delivery across Blood Brain Barrier Market, By Application, 2016 - 2026 (USD Million) Table 10 U.S. Drug Delivery across Blood Brain Barrier Market, By Drug Delivery Technology, 2016 - 2026 (USD Million) Table 11 Canada Drug Delivery across Blood Brain Barrier Market, By Application, 2016 - 2026 (USD Million) Table 12 Canada Drug Delivery across Blood Brain Barrier Market, By Drug Delivery Technology, 2016 - 2026 (USD Million) Table 13 Europe Drug Delivery across Blood Brain Barrier Market, By Country, 2016 - 2026 (USD Million) Table 14 Europe Drug Delivery across Blood Brain Barrier Market, By Application, 2016 - 2026 (USD Million) Table 15 Europe Drug Delivery across Blood Brain Barrier Market, By Drug Delivery Technology, 2016 - 2026 (USD Million) Table 16 UK Drug Delivery across Blood Brain Barrier Market, By Application, 2016 - 2026 (USD Million) Table 17 UK Drug Delivery across Blood Brain Barrier Market, By Drug Delivery Technology, 2016 - 2026 (USD Million) Table 18 Germany Drug Delivery across Blood Brain Barrier Market, By Application, 2016 - 2026 (USD Million) Table 19 Germany Drug Delivery across Blood Brain Barrier Market, By Drug Delivery Technology, 2016 - 2026 (USD Million) Table 20 France Drug Delivery across Blood Brain Barrier Market, By Application, 2016 - 2026 (USD Million) Table 21 France Drug Delivery across Blood Brain Barrier Market, By Drug Delivery Technology, 2016 - 2026 (USD Million) Table 22 Italy Drug Delivery across Blood Brain Barrier Market, By Application, 2016 - 2026 (USD Million) Table 23 Italy Drug Delivery across Blood Brain Barrier Market, By Drug Delivery Technology, 2016 - 2026 (USD Million) Table 24 Spain Drug Delivery across Blood Brain Barrier Market, By Application, 2016 - 2026 (USD Million) Table 25 Spain Drug Delivery across Blood Brain Barrier Market, By Drug Delivery Technology, 2016 - 2026 (USD Million) Table 26 Asia Pacific Drug Delivery across Blood Brain Barrier Market, By Country, 2016 - 2026 (USD Million) Table 27 Asia Pacific Drug Delivery across Blood Brain Barrier Market, By Application, 2016 - 2026 (USD Million) Table 28 Asia Pacific Drug Delivery across Blood Brain Barrier Market, By Drug Delivery Technology, 2016 - 2026 (USD Million) Table 29 Japan Drug Delivery across Blood Brain Barrier Market, By Application, 2016 - 2026 (USD Million) Table 30 Japan Drug Delivery across Blood Brain Barrier Market, By Drug Delivery Technology, 2016 - 2026 (USD Million) Table 31 China Drug Delivery across Blood Brain Barrier Market, By Application, 2016 - 2026 (USD Million) Table 32 China Drug Delivery across Blood Brain Barrier Market, By Drug Delivery Technology, 2016 - 2026 (USD Million) Table 33 India Drug Delivery across Blood Brain Barrier Market, By Application, 2016 - 2026 (USD Million) Table 34 India Drug Delivery across Blood Brain Barrier Market, By Drug Delivery Technology, 2016 - 2026 (USD Million) Table 35 Thailand Drug Delivery across Blood Brain Barrier Market, By Application, 2016 - 2026 (USD Million) Table 36 Thailand Drug Delivery across Blood Brain Barrier Market, By Drug Delivery Technology, 2016 - 2026 (USD Million) Table 37 South Korea Drug Delivery across Blood Brain Barrier Market, By Application, 2016 - 2026 (USD Million) Table 38 South Korea Drug Delivery across Blood Brain Barrier Market, By Drug Delivery Technology, 2016 - 2026 (USD Million) Table 39 Latin America Drug Delivery across Blood Brain Barrier Market, By Country, 2016 - 2026 (USD Million) Table 40 Latin America Drug Delivery across Blood Brain Barrier Market, By Application, 2016 - 2026 (USD Million) Table 41 Latin America Drug Delivery across Blood Brain Barrier Market, By Drug Delivery Technology, 2016 - 2026 (USD Million) Table 42 Brazil Drug Delivery across Blood Brain Barrier Market, By Application, 2016 - 2026 (USD Million) Table 43 Brazil Drug Delivery across Blood Brain Barrier Market, By Drug Delivery Technology, 2016 - 2026 (USD Million) Table 43 Mexico Drug Delivery across Blood Brain Barrier Market, By Application, 2016 - 2026 (USD Million) Table 45 Mexico Drug Delivery across Blood Brain Barrier Market, By Drug Delivery Technology, 2016 - 2026 (USD Million) Table 46 Argentina Drug Delivery across Blood Brain Barrier Market, By Application, 2016 - 2026 (USD Million) Table 47 Argentina Drug Delivery across Blood Brain Barrier Market, By Drug Delivery Technology, 2016 - 2026 (USD Million) Table 48 Colombia Drug Delivery across Blood Brain Barrier Market, By Application, 2016 - 2026 (USD Million) Table 49 Colombia Drug Delivery across Blood Brain Barrier Market, By Drug Delivery Technology, 2016 - 2026 (USD Million) Table 50 MEA Drug Delivery across Blood Brain Barrier Market, By Country, 2016 - 2026 (USD Million) Table 51 MEA Drug Delivery across Blood Brain Barrier Market, By Application, 2016 - 2026 (USD Million) Table 52 MEA Drug Delivery across Blood Brain Barrier Market, By Drug Delivery Technology, 2016 - 2026 (USD Million) Table 53 South Africa Drug Delivery across Blood Brain Barrier Market, By Application, 2016 - 2026 (USD Million) Table 54 South Africa Drug Delivery across Blood Brain Barrier Market, By Drug Delivery Technology, 2016 - 2026 (USD Million) Table 55 Saudi Arabia Drug Delivery across Blood Brain Barrier Market, By Application, 2016 - 2026 (USD Million) Table 56 Saudi Arabia Drug Delivery across Blood Brain Barrier Market, By Drug Delivery Technology, 2016 - 2026 (USD Million) Table 57 UAE Drug Delivery across Blood Brain Barrier Market, By Application, 2016 - 2026 (USD Million) Table 58 UAE Drug Delivery across Blood Brain Barrier Market, By Drug Delivery Technology, 2016 - 2026 (USD Million)
List of Figures Fig. 1 Market research process Fig. 2 Data triangulation techniques Fig. 3 Primary research pattern Fig. 4 Market research approaches Fig. 5 Value-chain-based sizing & forecasting Fig. 6 QFD modeling for market share assessment Fig. 7 Market formulation & validation Fig. 8 Drug delivery across blood brain barrier market :Market snapshot Fig. 9 Drug delivery across blood brain barrier market :Market segmentation Fig. 10 Drug delivery across blood brain barrier market Strategy framework Fig. 11 Parent market outlook Fig. 12 Related/ancillary market outlook Fig. 13 Drug delivery across blood brain barrier market driver impact Fig. 14 Drug delivery across blood brain barrier market restraint impact Fig. 15 Drug delivery across blood brain barrier market porter's five forces analysis Fig. 16 Drug delivery across blood brain barrier market PESTEL analysis Fig. 17 Drug delivery across blood brain barrier market segment dashboard Fig. 18 Drug delivery across blood brain barrier market: product type movement Analysis Fig. 19 Trojan Horse Approach Drug delivery across blood brain barrier market estimates and forecast, 2016 - 2026 (USD Million) Fig. 20 Bispecific Antibody RMT Approach Drug delivery across blood brain barrier market estimates and forecast, 2016 - 2026 (USD Million) Fig. 21 Increasing the Permeability of BBB Drug delivery across blood brain barrier market estimates and forecast, 2016 - 2026 (USD Million) Fig. 22 Passive Diffusion Drug delivery across blood brain barrier market estimates and forecast, 2016 - 2026 (USD Million) Fig. 23 Other Non-Invasive BBB Technologies Drug delivery across blood brain barrier market estimates and forecast, 2016 - 2026 (USD Million) Fig. 24 Drug delivery across blood brain barrier market segment dashboard Fig. 25 Drug delivery across blood brain barrier market: Application movement analysis Fig. 26 Alzheimer's Disease market estimates and forecast, 2016 - 2026 (USD Million) Fig. 27 Epilepsy market estimates and forecast, 2016 - 2026 (USD Million) Fig. 28 Parkinson's Disease market estimates and forecast, 2016 - 2026 (USD Million) Fig. 29 Multiple Sclerosis market estimates and forecast, 2016 - 2026 (USD Million) Fig. 30 Hunter's Syndrome market estimates and forecast, 2016 - 2026 (USD Million) Fig. 31 Brain Cancer market estimates and forecast, 2016 - 2026 (USD Million) Fig. 32 Others market estimates and forecast, 2016 - 2026 (USD Million) Fig. 33 Global Drug delivery across blood brain barrier market: Regional movement analysis Fig. 34 Global Drug delivery across blood brain barrier market: Regional outlook and key takeaways Fig. 35 Global market share, by region Fig. 36 North America market estimates and forecast, 2016 - 2026 (USD Million) Fig. 37 U.S. market estimates and forecast, 2016 - 2026 (USD Million) Fig. 38 Canada market estimates and forecast, 2016 - 2026 (USD Million) Fig. 39 Europe market estimates and forecast, 2016 - 2026 (USD Million) Fig. 40 UK market estimates and forecast, 2016 - 2026 (USD Million) Fig. 41 Germany market estimates and forecast, 2016 - 2026 (USD Million) Fig. 42 France market estimates and forecast, 2016 - 2026 (USD Million) Fig. 43 Italy market estimates and forecast, 2016 - 2026 (USD Million) Fig. 44 Spain market estimates and forecast, 2016 - 2026 (USD Million) Fig. 45 Asia Pacific market estimates and forecast, 2016 - 2026 (USD Million) Fig. 46 Japan market estimates and forecast, 2016 - 2026 (USD Million) Fig. 47 China market estimates and forecast, 2016 - 2026 (USD Million) Fig. 48 India market estimates and forecast, 2016 - 2026 (USD Million) Fig. 49 Thailand market estimates and forecast, 2016 - 2026 (USD Million) Fig. 50 South Korea market estimates and forecast, 2016 - 2026 (USD Million) Fig. 51 Latin America market estimates and forecast, 2016 - 2026 (USD Million) Fig. 52 Brazil market estimates and forecast, 2016 - 2026 (USD Million) Fig. 53 Mexico market estimates and forecast, 2016 - 2026 (USD Million) Fig. 54 Argentina market estimates and forecast, 2016 - 2026 (USD Million) Fig. 55 Colombia market estimates and forecast, 2016 - 2026 (USD Million) Fig. 56 Middle East and Africa. market estimates and forecast, 2016 - 2026 (USD Million) Fig. 57 South Africa market estimates and forecast, 2016 - 2026 (USD Million) Fig. 58 Saudi Arabia market estimates and forecast, 2016 - 2026 (USD Million) Fig. 59 UAE market estimates and forecast, 2016 - 2026 (USD Million)
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
